Authors

  • Базарбаев М.И., Сайфуллаева Д.И., Кадырбергенов Р.Б.

Keywords:

генетически модифицированные пробиотики; синтетическая биология; живые терапевтические системы; адаптивная регуляция экспрессии; сенсорные микроорганизмы; кишечная микробиота; локальный синтез биологически активных веществ; терапевтические белки; иммуномодуляторы; витамины; биобезопасность; генетическая безопасность (биоконтеймент).

References

Lee WM, Fontana RJ, Seeff LB, Björnsson ES, Thompson CM, Talwalkar JA, et al. Drug-induced liver injury: summary of a single topic clinical research conference. Mayo Clin Proc. 2014;89(1):95-106. doi:10. 1016/ j.mayocp.2013.09.016

Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and their health-promoting effects. Microbiol Spectr. 2017;5(3).

Ahmad M, Hirz M, Pichler H, Schwab H. Optimization of production of recombinant human growth hormone. Biotechnol Adv. 2012;30(5):1123-34.

Mavros CF, Bongers M, Neergaard FBF, Cusimano F, Sun Y, Kaufman A, et al. Bacteria engineered to produce serotonin modulate host intestinal physiology. ACS Synth Biol. 2024;13(12):4002-14. doi:10.10 21/acssynbio.4c00453

Beliavskaia VA, Cherdyntseva NV, Bondarenko VM, Litviakov NV. [Biological effects of interferon produced by recombinant bacteria of the probiotic preparation subalin]. Zh Mikrobiol Epidemiol Immunobiol. 2003;(2):102-9. Russian.

Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front Pharmacol. 2021; 12:618411. doi:10.3389/fphar.2021.618411

Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000; 289 (5483):1352-5. doi:10.1126/science.289. 5483.1352

Liu Y, Zhu Z, Jiang L. Programming therapeutic probiotics by self-tunable sen-se-and-respond genetic circuits. Trends Microbiol. 2023;31(11):1099-101. doi: 10. 1016/j.tim.2023.08.001

Zhang Y, Shang X, Lai S, Zhang G, Liang Y, Wen T. Development and application of an arabinose-inducible expression system by facilitating inducer uptake in Corynebacterium glutamicum. Appl Environ Microbiol. 2012;78(16):5831-8. doi: 10.1128/AEM.01147-12

Beckett D. Regulating transcription regulators via allostery and flexibility. Proc Natl Acad Sci U S A. 2009; 106(52): 22035-6. doi:10.1073/pnas.0912300107

Ravikumar S, Baylon MG, Park SJ, Choi JI. Engineered microbial biosensors based on bacterial two-component systems as synthetic biotechnology platforms in bioremediation and biorefinery. Microb Cell Fact. 2017;16(1):62. doi:10.1186/s12934-017-0675-z

Zhang J-Z, Li Y-Z, Xi Z-N, Zhang Y, Liu Z-Y, Ma X-Q, et al. Inducible promoters of bacterial microcompartments improve the CRISPR/Cas9 tools for efficient metabolic engineering of Clostridium ljungdahlii. Appl Environ Microbiol. 2025;91(4): e02 18324. doi:10.1128/aem.02183-24

Stirling F, Bitzan L, O'Keefe S, Redfield E, Oliver JWK, Way J, et al. Rational design of evolutionarily stable microbial kill switches. Mol Cell. 2017;68(4):686-97.e3. doi: 10.1016/j.molcel.2017.10.033. Errat-um in: Mol Cell. 2018;72(2):395. doi: 10.10 16/j.molcel.2018.10.002

Rottinghaus AG, Ferreiro A, Fishbein SRS, Dantas G, Moon TS. Genetically stable CRISPR-based kill switches for engineered microbes. Nat Commun. 2022 ;13(1):672. doi:10.1038/s41467-022-2816 3-5

Chan CT, Lee JW, Cameron DE, Bashor CJ, Collins JJ. 'Deadman' and 'Passcode' microbial kill switches for bacterial containment. Nat Chem Biol. 2016;12(2):82-6. doi:10.1038/nchembio.1979

Jawalagatti V, Kirthika P, Lee JH. Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium. Mol Ther Oncolytics. 2022; 25:350-63. doi: 10.1016/j.omto.20 22.05.004

Rottinghaus AG, Amrofell MB, Moon TS. Biosensing in smart engineered probiotics. Biotechnol J. 2020;15(10): e190 0319. doi:10.1002/biot.201900319

Xia JY, Hepler C, Tran P, Waldeck NJ, Bass J, Prindle A. Engineered calprotectin-sensing probiotics for IBD surveillance in humans. Proc Natl Acad Sci U S A. 2023; 120(32): e2221121120. doi:10.1073/pnas. 2221121120

Armstrong A, Isalan M. Engineering bacterial theranostics: from logic gates to in vivo applications. Front Bioeng Biotechnol. 2024; 12:1437301. doi:10. 3389/ fbioe.2024.1437301

Sadhu S, Paul T, Yadav N. Therapeutic engineering of the gut microbiome using synthetic biology and metabolic tools: a comprehensive review with E. coli Nissle 1917 as a model case study. Arch Microbiol. 2025;207(9):213. doi:10.1007/s00203-025 -04417-w

Liu L, Helal SE, Peng N. CRISPR-Cas-based engineering of probiotics. Biodes Res. 2023; 5:0017. doi:10.34133/bdr.0017

Riglar DT, Giessen TW, Baym M, Kerns SJ, Niederhuber MJ, Bronson RT, et al. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nat Biotechnol. 2017; 35(7):653-8. doi:10.1038/nbt.3879.

Recent advances of engineered probiotics for therapeutic applications. Current Research in Microbial Sciences. 2025; 6: 100240. Doi: 10.1016/ j.crmicr.2024.100 240.

Engineered probiotics: a new era in treating inflammatory bowel disease. Frontiers in Microbiology. 2025; 16: 1449 580. Doi: 10.3389/fmicb.2025.1449580.

Recent advances in therapeutic probiotics: insights from human trials. Clinical Microbiology Reviews. 2025; e00240-24. Doi: 10.1128/cmr.00240-24.

Probiotic Bacteria as Therapeutics and Biohybrid Drug Carriers: Advances, Design Strategies, and Future Outlook. ACS Applied Bio Materials. 2025; 8(12): 7880-7897. Doi: 10.1021/acsabm.5c00959.

Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. Microorganisms. 2024; 12(3): 430. Doi: 10.3390/microorganisms12030430.

Recent advances in single-cell engineered live biotherapeutic products research for skin repair and disease treatment. npj Biofilms and Microbiomes. 2023; 9: 88. Doi: 10.1038/s41522-023-00463-8.